Astrana Health Inc. (ASTH)

Astrana Health reported strong Q1 2025 financial results, with total revenue reaching $620.4 million, a 53% year-over-year increase, but net income decreased to $6.7 million. The company reported strong Q2 2025 financial results, with total revenue reaching $654.8 million, up 35% year-over-year, and adjusted EBITDA of $48.1 million. Astrana Health announced the closing of the Prospect Health acquisition for $707.9 million on July 1, 2025, and successfully integrated Collaborative Health Systems. Astrana Health strengthened its leadership team with several strategic appointments, including Sherry McBride as Chief Operating Officer. The company participated in the William Blair 2025 Growth Stock Conference in June 2025 and scheduled its Q3 2025 financial results release for November 6, 2025. As of October 17, 2025, the share price was $32.01, representing a decline of 46.75% from October 21, 2024, though shares have seen an increase of 8.3% over the last six months.

While there is no explicit information detailing seasonality for Astrana Health's products and services, general seasonality analysis for the ASTH stock suggests that October historically favors a long bias. The demand for its core medical care services is likely to be relatively stable throughout the year, rather than exhibiting strong seasonal fluctuations.

Astrana Health, Inc. operates within the Healthcare sector, specifically in Medical Care Facilities or Healthcare Providers & Services. The company's operations are structured across three main segments: Care Partners focuses on building and managing provider networks, Care Delivery provides primary care, multi-specialty care, and ancillary care services, and Care Enablement offers an integrated clinical and administrative platform. Astrana Health offers care coordination services to a wide range of stakeholders and serves patients primarily covered by private or public insurance, as well as non-insured patients.

Astrana Health, Inc. provides medical care services across the United States. The company manages over one million members through a network of more than 12,000 providers across 32 markets. Its headquarters are located in Alhambra, California.

Astrana Health's brand reputation appears to be generally positive, particularly in relation to its financial performance and strategic growth. Analysts have maintained a "Strong Buy" consensus rating for the stock, with a bullish blogger sentiment. The company's commitment to a value-based care model and its technology-driven approach are seen as key strengths.

Approximately 52.8% of Astrana Health shares are owned by institutional investors, including BlackRock, Inc., Vanguard Group Inc, iShares Core S&P Small-Cap ETF (IJR), State Street Corp, and Dimensional Fund Advisors Lp. Insiders own about 20.0% of Astrana Health shares, with Kenneth T. Sim being the largest individual shareholder, owning 33.93 million shares, representing 60.52% of the company. Thomas S. Lam and Albert Waichow Young are also significant individual owners.